Commitments and Contingencies (Details) $ in Thousands		1 Months Ended	3 Months Ended		9 Months Ended
Commitments and Contingencies (Details) $ in Thousands	Jul. 05, 2013 USD ($) product	Jun. 30, 2024 USD ($)	Sep. 30, 2026 USD ($)	Sep. 30, 2025 USD ($)	Sep. 30, 2026 USD ($)	Sep. 30, 2025 USD ($)	Jun. 30, 2025 USD ($)
Commitments And Contingencies [Line Items]
Cost of license revenue			$ 100	$ 0	$ 9,100	$ 0
Yale University
Commitments And Contingencies [Line Items]
Cost of license revenue			$ 100		$ 9,100
Yale University \| Maximum
Commitments And Contingencies [Line Items]
Royalty payment	$ 500
Yale University \| Minimum
Commitments And Contingencies [Line Items]
Annual payment for license	$ 100
Number of licensed products \| product	2
Royalty payment	$ 200
Yale University \| Upfront Payment for Amended License Agreement and Novartis License and Asset Agreements
Commitments And Contingencies [Line Items]
Payments for collaboration		$ 14,950
Yale University \| Milestone Payment on First Anniversary of Signing
Commitments And Contingencies [Line Items]
Milestone payment the Company will make							$ 5,000
Yale University \| Milestone Payment Upon Approval of First and Second Royalty Products \| Maximum
Commitments And Contingencies [Line Items]
Milestone payment the Company will make		$ 15,000
Yale University \| Success-Based Milestone Payments \| License First Licensed Product
Commitments And Contingencies [Line Items]
Required milestone payments	3,000
Yale University \| Success-Based Milestone Payments \| License Second Licensed Product
Commitments And Contingencies [Line Items]
Required milestone payments	$ 1,500